Patent details
EP2117562 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS
Basic Information
- Publication number:
- EP2117562
- PCT Application Number:
- PCT/EP/2008/050622
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087080263
- PCT Publication Number:
- WO/2008/090115
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES CONTENANT DES ANTAGONISTES DU RÉCEPTEUR DE NK1 ET DES BLOQUEURS DE CANAL SODIQUE
- German Title of Invention:
- PHARMAZEUTISCHE ZUBEREITUNGEN MIT NK1-REZEPTOR-ANTAGONISTEN UND NATRIUMKANALBLOCKERN
- SPC Number:
Dates
- Filing date:
- 21/01/2008
- Grant date:
- 26/10/2011
- EP Publication Date:
- 26/10/2011
- PCT Publication Date:
- 03/02/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/11/2009
- EP B1 Publication Date:
- 26/10/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/01/2012
- Expiration date:
- 21/01/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/01/2008
- Name:
- Glaxo Group Limited
- Address:
- Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom (GB)
Inventor
1
- Name:
- LARGE Charles
- Address:
- Italy (IT)
2
- Name:
- ALVARO Giuseppe
- Address:
- Italy (IT)
Priority
- Priority Number:
- 0701366
- Priority Date:
- 24/01/2007
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/704;
| Filing date | Document type | Number of pages |
|---|